Disease-Modifying Therapies in Frontotemporal Lobar Degeneration

E-ISSN： 1875-533x|19|7|1008-1020

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.7, 2012-03, pp. : 1008-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Contributors to Frontotemporal Lobar Degeneration: Beyond Monogenic Disease

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-10 ,pp. : 988-1001

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2433-2455

Bentham Science Publishers

Access to resources Recommend Favorite

Disease-Modifying Therapies for Osteoarthritis: Current Status

By Marc Fajardo Paul E. Di Cesare

Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. : 141-161

Adis International

Access to resources Recommend Favorite

Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management

By Rabinovici Gil D. Miller Bruce L.

CNS Drugs, Vol. 24, Iss. 5, 2010-05 ,pp. : 375-398

Adis International

Access to resources Recommend Favorite

Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management

By Seltman Rachel E. Matthews Brandy R.

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 841-870

Adis International

Access to resources Recommend Favorite